A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

United States

Research Site, Aurora, Colorado

Research Site, Cincinnati, Ohio

Research Site, Highland Hills, Ohio

Brazil

Research Site, São Paulo

Canada

Research Site, Toronto, Ontario

France

Research Site, Lille

Research Site, Montpellier

India

Research Site, Ahmedabad

Mexico

Research Site, Guadalajara

Netherlands

Research Site, Rotterdam

Poland

Research Site, Kielce

Turkey (Türkiye)

Research Site, Altındağ

Research Site, Istanbul